Tenofovir & Emtricitabine

Tenofovir & Emtricitabine

Form: Tablet

Strength: Tenofovir DF 300 mg + Emtricitabine 200 mg

Reference Brands: Truvada®(US/EU)

Category: Anti Viral

Tenofovir & Emtricitabine Tablets (300 mg/200 mg), marketed under brands like Truvada®, Tenvir-EM®, and Ricovir-EM®, are WHO-recommended antiretrovirals used for both HIV-1 treatment and pre-exposure prophylaxis (PrEP). This fixed-dose, once-daily combination offers high efficacy with a strong safety profile. On PharmaB2B platforms, global buyers, NGOs, and procurement agencies can source WHO-GMP and USFDA-approved formulations in bulk from trusted manufacturers. Ideal for HIV prevention programs, public health supply chains, and international tenders, Tenofovir + Emtricitabine supports global access to affordable, life-saving HIV care. Partner with reliable suppliers for consistent, quality-assured ARV supply.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zanamivir

Strength: 5 mg/blister

Form: Inhalation powder

Reference Brands: Relenza(EU & US)

View Details Get Enquiry
Oseltamivir Phosphate Capsule

Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)

Form: Capsules and Oral solution

Reference Brands: Tamiflu(EU & US)

View Details Get Enquiry
Amantadine

Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg

Form: Tablet; Capsule; Oral Solution and ER Capsule

Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)

View Details Get Enquiry
Glecaprevir + Pibrentasvir

Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.